Pivotport moves to 'Scale' stage with $150,000 Azure Credits Grant

Rajiv Rajiv • 9/29/2024
Share:

Pivotport, Inc. has achieved a significant milestone by successfully completing its “Grow” (Level 3) stage in the Microsoft for Startup Founders program. As of August 15, 2024, Microsoft has granted approval for Pivotport to advance to the “Scale” (Level 4) stage, accompanied by a substantial grant of $150,000 in Azure Credits.

Enhanced Technical Capabilities

This advancement enables Pivotport to transform its MVP into a fully architected system for Cardiac Anomaly detection, leveraging Microsoft’s comprehensive suite of tools and services:

Strategic Implementation

The granted Azure Credits will be utilized over the next twelve months through collaborative efforts in Quantum Cardiac Anomaly Detection and Identification pilot projects. This funding will support the development and deployment of our innovative healthcare solutions.

Collaboration Opportunities

Pivotport is actively seeking collaboration with researchers and companies interested in quantum computing applications in healthcare. If you’re interested in exploring potential partnerships or pilot projects, please contact:

This milestone represents a significant step forward in Pivotport’s mission to revolutionize healthcare through quantum computing and artificial intelligence, enabling us to scale our solutions and impact in the healthcare sector.